Strive Asset Management (ASST) investor relations material

Executive summary

• Adopted a bitcoin-focused treasury strategy, using bitcoin as a hurdle rate for capital deployment and value creation.

• Completed the Semler Scientific Merger, adding medical device operations and assets.

• Acquired 6,236 bitcoin in Q2 2026 and 12,237 bitcoin in the first half of 2026, with an additional 303 bitcoin acquired post-quarter end.

• Issued significant equity and preferred stock, expanding capital markets activity and liquidity.

• Retired all outstanding short and long-term debt, leaving the company debt-free as of August 7, 2026.

Financial highlights

• Total revenues for Q2 2026 were $2.9M, up 94.6% year-over-year, driven by medical device revenues post-merger.

• Net loss attributable to common stockholders for Q2 2026 was $(283.8)M, compared to $(8.9)M in Q2 2025.

• Net unrealized loss on digital assets for Q2 2026 was $(228.0)M; for the six months ended June 30, 2026, $(523.8)M.

• Declared $26.2M in preferred stock dividends for Q2 2026 at a 13.00% annual rate.

• Operating expenses for Q2 2026 were $24.4M, up from $5.2M in Q2 2025.

Outlook and guidance

• Management believes liquidity is sufficient to meet strategic and working capital needs for at least the next twelve months.

• Plans to continue capital markets activity and bitcoin acquisitions, with $4.4B available for future equity and preferred stock issuance.

• Management believes daily dividend innovation will drive long-term accretive Bitcoin yield for equity shareholders.

• Forward-looking statements highlight risks related to Bitcoin treasury strategies, market conditions, and integration of recent merger activities.